RB1 and neoplasm: At the early stage of G1, active CDK4 and CDK6 phosphorylate retinoblastoma (RB) protein (a tumor inhibitor), leading to partial release of E2F transcription factor, and then promoting the transcription of downstream genes required to enter S phase through G1 restriction point (Morgan, 1997; Lundberg and Weinberg, 1998).